The neuronal microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles in the brains of individuals with Alzheimer's disease and related neurodegenerative disorders. The adult human brain expresses six isoforms of tau generated by alternative splicing of exons 2, 3, and 10 of its pre-mRNA. Exon 10 encodes the second microtubule-binding repeat of tau. Its alternative splicing produces tau isoforms with either three or four microtubule-binding repeats, termed 3R-tau and 4Rtau. In the normal adult human brain, the level of 3R-tau is approximately equal to that of 4R-tau. Several silent and intronic mutations of the tau gene associated with FTDP-17T(frontotemporal dementia with Parkinsonism linked to chromosome 17 and specifi cally characterized by tau pathology) only disrupt exon 10 splicing, but do not infl uence the primary sequence of the tau protein. Thus, abnormal exon 10 splicing is suffi cient to cause neurodegeneration and dementia. Here, we review the regulation of tau exon 10 splicing by cis-elements and trans-factors and summarize all the mutations associated with FTDP-17T and related tauopathies. The fi ndings suggest that correction of exon 10 splicing may be a potential target for tau exon 10 splicing-related tauopathies.
